首页> 外文期刊>American Journal of Kidney Diseases: The official journal of the National Kidney Foundation >High-Dose Versus Conventional-Dose Continuous Venovenous Hemodiafiltration and Patient and Kidney Survival and Cytokine Removal in Sepsis-Associated Acute Kidney Injury: A Randomized Controlled Trial
【24h】

High-Dose Versus Conventional-Dose Continuous Venovenous Hemodiafiltration and Patient and Kidney Survival and Cytokine Removal in Sepsis-Associated Acute Kidney Injury: A Randomized Controlled Trial

机译:高剂量与常规剂量连续的静脉血液血液血液腐败和患者和肾脏存活和细胞因子去除在败血症相关的急性肾损伤中:随机对照试验

获取原文
获取原文并翻译 | 示例
           

摘要

Background: Soluble inflammatory mediators are known to exacerbate sepsis-induced acute kidney injury (AKI). Continuous renal replacement therapy (CRRT) has been suggested to play a part in immunomodulation by cytokine removal. However, the effect of continuous venovenous hemodiafiltration (CVVHDF) dose on inflammatory cytokine removal and its influence on patient outcomes are not yet clear.
机译:背景:已知可溶性炎症介质加剧脓毒症诱导的急性肾损伤(AKI)。 已经提出连续肾脏替代疗法(CRRT)通过细胞因子去除,在免疫调节中发挥免疫调节部分。 然而,连续静脉血液血液血液血氧(CVVHDF)剂量对炎症细胞因子去除的影响及其对患者结果的影响尚不清楚。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号